Contemporary management of fibromuscular dysplasia

Current Opinion in Cardiology

Volumn 23, Issue 6, 2008, Pages 527-536

  Olin, Jeffrey W ^a   Pierce, Matthew ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Carotid artery disease; Fibromuscular dysplasia; Hypertension; Renal artery disease; Stroke

Indexed keywords

ACETYLSALICYLIC ACID;

ANEURYSM; ARTERY; CEREBROVASCULAR FIBROMUSCULAR DYSPLASIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISSECTION; FIBROMUSCULAR DYSPLASIA; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; RENAL ARTERY FIBROMUSCULAR DYSPLASIA; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; ULTRASOUND;

CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROMUSCULAR DYSPLASIA; HUMANS; MALE; PROGNOSIS; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RISK FACTORS; SEX FACTORS;

EID: 55149084775     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328313119a     Document Type: Review

References (96)

1. Stokes JB, Bonsib SM, McBride JW. Diffuse intimai fibromuscular dysplasia with multiorgan failure. Arch Intern Med 1996; 156:2611-2614.
2. Stanley JC, Gewertz BL, Bove EL, et al. Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg 1975; 110:561-566.
3. Harrison EG, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971; 46:161-167.
4. McCormack LJ, Routasse EF, Meaney TF, et al. A pathologic-arteriographic correlation of renal arterial disease. Am Heart J 1966; 72:188-198.
5. Begelman SM, Olin JW. Fibromuscular dysplasia. Curr Opin Rheumatol 2000; 12:41-47.
6. Olin JW. Recognizing and managing fibromuscular dysplasia. Cleve Clin J Med 2007; 74:273-274; 277-282.
7. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med 1980; 140:233-236.
8. Grimbert P, Fiquet-Kempf B, Coudol P, et al. Étude génétique de la dysplasie fibromusculaire des artères rénales. Arch Mal Coeur Vaiss 1998; 91:1069-1071.
9. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, et al. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens 1997; 15:1797-1801.
10. Perdu J, Boutouyrie P, Bourgain C, et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens 2007; 21:393-400. This study analyzes six families, using an arterial scoring system as a surrogate marker for renal FMD. Of interest, the article further defines the genetic component of the disease by demonstrating that it is systemic and inheritable.
11. Sang CN, Whelton PK, Hamper UM, et al. Etiologic factors in renovascular fibromuscular dysplasia: a case-control study. Hypertension 1989; 14:472-479.
12. Bofinger A, Hawley C, Fisher P, et al. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens 2001; 15:185-190.
13. Luscher TF, Lie JT, Stanson AW, et al. Arterial fibromuscular dysplasia. Mayo Clin Proc 1987; 62:931-952.
14. Schievink WI, Meyer FB, Parisi JE, et al. Fibromuscular dysplasia of the internal carotid artery associated with alpha-1 -antitrypsin deficiency. Neurosurgery 1998; 43:229-234.
15. Perdu J, Gimenez-Roqueplo AP, Boutouyrie P, et al. Alphal antitrypsin gene polymorphisms are not associated with renal arterial fibromusoular dysplasia. J Hypertens 2006; 24:705-710.
16. Hudgins LB, Limbacher JP II. Fibromuscular dysplasia in Alport's syndrome. J Tenn Med Assoc 1982; 75:733-735.
17. Qunibi WJ, Taylor TK, Knight TF, et al. Pheochromocytomaand fibromuscular hyperplasia. South Med J 1979; 72:1481-1482.
18. de Mendonca WC, Espat PA. Pheochromocytoma associated with arterial fibromuscular dysplasia. Am J Clin Pathol 1981; 75:749-754.
19. Schievink WI, Bjornsson J, Piepgras DG. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marian's syndrome and bilateral carotid artery dissections. Stroke 1994; 25:2492-2496.
20. Janzen J, Vuong PN, Rothenberger-Janzen K. Takayasu's arteritis and fibromuscular dysplasia as causes of acquired atypical coarctation of the aorta: retrospective analysis of seven cases. Heart Vessels 1999; 14:277-282.
21. D'Souza SJ, Tsai WS, Silver MM, et al. Diagnosis and management of stenotic aorto-arteriopathy in childhood. J Pediatr 1998; 132:1016-1022.
22. Schievink WI, Limburg M. Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlers-Danlos syndrome, type IV. Neurosurgery 1989; 25:482-483.
23. de Bray JM, Marc G, Pautot V, et al. Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis 2007; 23:448-452. This prospective study assesses the rate of ischemic stroke or TIA due to the recurrence of cervical artery dissection. This study found that, when symptomatic, the recurrence of cervical dissection was often related to FMD.
24. Jaff MR, Olin JW, Young JR. Failure of acute phase reactants to predict disease activity in Takayasu's arteritis. J Vasc Med Biol 1993; 4:223-227.
25. Gowda MS, Loeb AL, Crouse LJ, Kramer PH. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the 'gold standard'? J Am Coll Cardiol 2003; 41:1305-1311.
26. Flamm SD, White RD, Hoffman GS. The clinical application of 'edema-weighted' magnetic resonance imaging in the assessment of Takayasu's arteritis. Int J Cardiol 1998; 66 (Suppl 1):S151-S161.
27. Das CJ, Neyaz Z, Thapa P, et al. Fibromuscular dysplasia of the renal arteries: a radiological review, Int Ural Nephrol 2007; 39:233-238.
28. Slovut DP, Olin JW. Current concepts: fibromuscular dysplasia. N Engl J Med 2004; 350:1862-1871.
29. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001; 344:431-442.
30. Sperati CJ, Aggarwal N, Arepally A, Atta MG. Fibromuscular dysplasia. Kidney Int 2008 Jun 4 [Epub ahead of print]
31. Kincaid OW, Davis GD, Hallermann FJ, Hunt JC. Fibromuscular dysplasia of the renal arteries: arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med 1968; 104:271-282.
32. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984; 11:383-392.
33. Goncharenko V, Gerlock AJ Jr, Shaff MI, Hollifield JW. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology 1981; 139:45-51.
34. Mounier-Vehier C, Lions C, Jaboureck O, et al. Parenchymal consequences of fibromuscular dysplasia renal artery stenosis. Am J Kidney Dis 2002; 40: 1138-1145.
35. Malago R, D'Onofrio M, Mucelli RP. Fibromuscular dysplasia: noninvasive evaluation of unusual case of renal and mesenteric involvement. Urology 2008; 71:755e13-755e15.
36. Rubin GD. MDCT imaging of the aorta and peripheral vessels. Eur J Radiol 2003; 45 (Suppl 1):S42-S49.
37. Funabashi N, Komiyama N, Komuro I. Fibromuscular dysplasia in renovascular hypertension demonstrated by multislice CT: comparison with conventional angiogram and intravascular ultrasound. Heart 2003; 89:639.
38. Olin JW, Piedmonte M, Young JR, et al. Utility of duplex scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995; 122:833-838.
39. Carman TL, Olin JW, Czum J. Noninvasive imaging of renal arteries. Urol Clin North Am 2001; 28:815-826.
40. Napoli V, Pinto S, Bargellini I, et al. Duplex ultrasonographic study of the renal arteries before and after renal artery stenting. Eur Radiol 2002; 12:796-803.
41. Edwards JM, Zaccardi MJ, Strandness DE Jr. A preliminary study of the role of duplex scanning in defining the adequacy of treatment of patients with renal artery fibromuscular dysplasia. J Vasc Surg 1992; 15:604-611.
42. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
43. Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309:274-279.
44. Baert AL, Wilms G, Amery A, et al. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol 1990; 13:22-28.
45. Tegtmeyer CJ, Selby JB, Hartwell GD, et al. Results and complications of angioplasty in fibromuscular disease. Circulation 1991; 83 (Suppl 1):1-155-1-161.
46. Bonelli FS, McKusick MA, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995; 70:1041-1052.
47. Jensen G, Zachrisson BF, Delin K, et al. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995; 48:1936-1945.
48. Davidson RA, Barri Y, Wilcox CS. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis 1996; 28:334-338.
49. Klow NE, Paulsen D, Vatne K, et al. Percutaneous transluminal renal artery angioplasty using the coaxial technique: ten years of experience from 591 procedures in 419 patients. Acta Radiol 1998; 39:594-603.
50. Birrer M, Do DD, Mahler F, et al. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002; 23:146-152.
51. Surowiec SM, Sivamurthy N, Rhodes JM, et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 2003; 17:650-655.
52. de Fraissinette B, Garcier JM, Dieu V, et al. Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol 2003; 26:46-51.
53. Kirn HJ, Do YS, Shin SW, et al. Percutaneous transluminal angioplasty of renal artery fibromuscular dysplasia: mid-term results. Korean J Radiol 2008; 9:38-44. This study examines the effectiveness of PTA in treating patients with FMD of the renal arteries. This study confirms that this form of treatment is effective and safe for those with symptomatic renal FMD.
54. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) - summary of recommendations. J Vasc Interv Radiol 2006; 17:1383-1398.
55. Luscher TF, Keller HM, Imhof HG, et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome: results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986; 44:109-114.
56. Anderson CA, Hansen KJ, Benjamin ME, et al. Renal artery fibromuscular dysplasia: results of current surgical therapy. J Vasc Surg 1995; 22:207-216.
57. Hagg A, Aberg H, Eriksson I, et al. Fibromuscular dysplasia of the renal artery - management and outcome. Acta Chir Scand 1987; 153:15-20.
58. Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease: ten years' experience. JAMA 1987; 257:498-501.
59. Airoldi F, Palatresi S, Marana I, et al. Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens 2000; 13:1210-1217.
60. Archibald GR, Beckmann CF, Libertino JA. Focal renal artery stenosis caused by fibromuscular dysplasia: treatment by percutaneous transluminal angioplasty. AJR Am J Roentgenol 1988; 151:593-596.
61. Cluzel P, Raynaud A, Beyssen B, et al. Stenoses of renal branch arteries in fibromuscular dysplasia: results of percutaneous transluminal angioplasty. Radiology 1994; 193:227-232.
62. Plouin PF, Darne B, Chatellier G, et al. Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension 1993; 21:89-96.
63. Baumgartner I, Triller J, Mahler F. Patency of percutaneous transluminal renal angioplasty: a prospective sonographic study. Kidney Int 1997; 51:798-803.
64. Mettinger KL. Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke 1982; 13:53-58.
65. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 1982; 13:46-52.
66. Van Damme H, Sakalihasan N, Limet R. Fibromuscular dysplasia of the internal carotid artery: personal experience with 13 cases and literature review. Acta Chir Belg 1999; 99:163-168.
67. de Monyé C, Dippel DW, Dijkshoorn ML, et al. MDCT detection of fibromuscular dysplasia of the internal carotid artery. AJR Am J Roentgenol 2007; 188:W367-W369. This article describes two case reports in which CT angiography was used to diagnose FMD of the internal carotid arteries. The authors review the characteristic changes in FMD that can be visualized on CTA.
68. Plouin PF, Perdu J, La Batide-Alanore A, et al. Fibromuscular dysplasia. Orphanet J Rare Dis 2007; 2:28-35.
69. Effeney DJ, Krupski WC, Storey RJ, Ehrenfeld WK. Fibromuscular dysplasia of the carotid artery. Aust N Z J Surg 1983; 53:527-531.
70. Arning C, Grzyska U. Color Doppler imaging of cervicocephalic fibromuscular dysplasia. Cardiovasc Ultrasound 2004; 2:7.
71. Stewart MT, Moritz MW, Smith RB III, et al. The natural history of carotid fibromuscular dysplasia. J Vasc Surg 1986; 3:305-310.
72. Wells RP, Smith RR. Fibromuscular dysplasia of the internal carotid artery: a long term follow-up. Neurosurgery 1982; 10:39-43.
73. Ballard JL, Guinn JE, Killeen JD, Smith DC. Open operative balloon angioplasty of the internal carotid artery: a technique in evolution. Ann Vasc Surg 1995; 9:390-393.
74. Brown MM. Balloon angioplasty for cerebrovascular disease. Neurol Res 1992; 14 (Suppl):159-163.
75. Garrido E, Montoya J. Transluminal dilatation of internal carotid artery in fibromuscular dysplasia: a preliminary report. Surg Neurol 1981; 16:469-471.
76. Belan A, Vesela M, Vanek I, et al. Percutaneous transluminal angioplasty of fibromuscular dysplasia of the internal carotid artery. Cardiovasc Intervent Radiol 1982; 5:79-81.
77. Wilms GE, Smits J, Baert AL, De Wolf L. Percutaneous transluminal angioplasty in fibromuscular dysplasia of the internal carotid artery: one year clinical and morphological follow-up. Cardiovasc Intervent Radiol 1985; 8:20-23.
78. Dublin AB, Baltaxe HA, Cobb CA III. Percutaneous transluminal carotid angioplasty and detachable balloon embolization in fibromuscular dysplasia. AJNR Am J Neuroradiol 1984; 5:646-648.
79. Welch EL, Lemkin JA, Geary JE. Gruntzig balloon dilation for fibromuscular dysplasia of the internal carotid arteries. NY State J Med 1985; 85:115-117.
80. Tsai FY, Matovich V, Hieshima G, et al. Percutaneous transluminal angioplasty of the carotid artery. AJNR Am J Neuroradiol 1986; 7:349-358.
81. Edgell RC, Abou-Chebl A, Yadav JS. Endovascular management of spontaneous carotid artery dissection. J Vasc Surg 2005; 42:854-860; discussion 860.
82. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001; 344:898-906.
83. Kim JS, Mukherjee D. Current status of carotid stenting. Curr Vasc Pharmacol 2008; 6:143-147.
84. van den Dungen JJ, Boontje AH, Oosterhuis JW. Femoropopliteal arterial fibrodysplasia. Br J Surg 1990; 77:396-399.
85. Vertruyen M, Garcez JL. Rbromuscular dysplasia of the superficial femoral artery: an unusual localization. Acta Chir Belg 1993; 93:249-251.
86. Cutts S, Grewal RS, Downing R. Bilateral brachial artery fibromuscular dysplasia. Eur J Vasc Endovasc Surg 2000; 19:667-668.
87. Suzuki H, Daida H, Sakurai H, Yamaguchi H. Familial fibromuscular dysplasia of bilateral brachial arteries. Heart 1999; 82:251-252.
88. Yoshida T, Ohashi I, Suzuki S, Iwai T. Fibromuscular disease of the brachial artery with digital emboli treated effectively by transluminal angioplasty. Cardiovasc Intervent Radiol 1994; 17:99-101.
89. Mandke JV, Sharma S, Phatak AM, et al. Catheter atherectomy of intimal fibroplasia of the common iliac artery. Cathet Cardiovasc Diagn 1993; 30:30-32.
90. Insall RL, Chamberlain J, Loose HW. Fibromuscular dysplasia of visceral arteries. Eur J Vasc Surg 1992; 6:668-672.
91. Yamaguchi R, Yamaguchi A, Isogai M, et al. Fibromuscular dysplasia of the visceral arteries. Am J Gastroenterol 1996; 91:1635-1638.
92. Nerantzis CE, Kalogrias NF, Letsas KP, et al. Postmortem angiographic and histologic findings of coronary artery fibromuscular dysplasia. Int J Cardiol 2007; 122:e32-e35.
93. Guill CK, Benavides DC, Rees C, et al. Fatal mesenteric fibromuscular dysplasia: a case report and review of the literature. Arch Intern Med 2004; 164:1148-1153.
94. Camuglia A, Manins V, Taylor A, Hengel C. Case report and review: epicardial coronary artery fibromuscular dysplasia. Heart Lung Circ 2008. [Epub ahead of print]
95. Huizar JF, Awasthi A, Kozman H. Fibromuscular dysplasia and acute myocardial infarction: evidence for a unique clinical and angiographic pattern. J Invasive Cardiol 2006; 18:E99-E101.
96. Pate GE, Lowe R, Buller CE. Fibromuscular dysplasia of the coronary and renal arteries? Catheter Cardiovasc Interv 2005; 64:138-145.